A Study to Verify the Clinical Benefit of Aducanumab in Participants With Early Alzheimer's Disease

NCT05310071 · clinicaltrials.gov ↗
PHASE3
Phase
TERMINATED
Status
1027
Enrollment
INDUSTRY
Sponsor class

Stopped Sponsor's Decision

Conditions

Interventions

Sponsor

Biogen